Analysed OLYMPUS CORP - ADR (OLYMY:OTCMKTS) News Sources
Disposable Endoscope Analysis Report 2025: A $4.95 Billion Market by 2029 - Aging Population and Growing Healthcare Expenditure Accelerate Shift Toward Disposable Endoscopic Solutions
17-02-2026
yahoo.com
EAGLE Trial Shows Olympus(R) CADDIE(TM) AI Solution Aids in the Detection of High-Risk and Hard-to-Detect Colorectal Lesions
03-02-2026
yahoo.com
Should Olympus’ PolyLoop Recall and VIABIL Deal Reshape the Medtech Story for Olympus (TSE:7733) Investors?
08-12-2025
yahoo.com
Olympus, Gore, and ConMed Announce Transition of Commercial Support for the GORE® VIABIL® Biliary Endoprosthesis in the United States
05-12-2025
yahoo.com
Swan EndoSurgical Appoints Veteran Robotics and MedTech Leader Erik Todd as Chief Executive Officer
02-12-2025
yahoo.com
Olympus Unveils Corporate Strategy; Shaping the Future of Endoscopy-Enabled Care Through Innovation and Operational Excellence
07-11-2025
yahoo.com
Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center
29-10-2025
yahoo.com
Olympus and W. L. Gore & Associates Enter into International Distribution Agreement to Expand the Olympus EndoTherapy Portfolio
06-10-2025
yahoo.com
What is the current price of OLYMPUS CORP - ADR (OLYMY:OTCMKTS)?
The current price of OLYMPUS CORP - ADR (OLYMY:OTCMKTS) is $9.677.
OLYMPUS CORP - ADR (OLYMY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of OLYMPUS CORP - ADR (OLYMY:OTCMKTS) since the previous trading day is $-0.263.
OLYMPUS CORP - ADR (OLYMY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of OLYMPUS CORP - ADR (OLYMY:OTCMKTS) since the previous trading day is -2.6459%.
What is the most recent average sentiment score for OLYMPUS CORP - ADR (OLYMY:OTCMKTS)?
The most recent average sentiment score for OLYMPUS CORP - ADR (OLYMY:OTCMKTS) is 75 out of 100.
What is the most recent average sentiment for OLYMPUS CORP - ADR (OLYMY:OTCMKTS)?
The most recent sentiment for OLYMPUS CORP - ADR (OLYMY:OTCMKTS) is .
SEC-8K** Filing Available For OLYMPUS CORP - ADR (OLYMY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.